Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017
Surgical morbidity and mortality in lung cancer patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006
Mortality outcomes in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a real world study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021
Out-patient pulmonary rehabilitation program reduce hospital utilisation in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 593s Year: 2002
Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease Source: Eur Respir J 2013; 42: 444-453 Year: 2013
Effect of benzodiazepines in hospital readmissions and mortality in patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Pharmacological management of COPD Year: 2018
Effects of short-term pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 628s Year: 2006
Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017
Survival benefit of lung transplantation compared with medical management and pulmonary rehabilitation for patients with end-stage COPD Source: ERJ Open Res, 6 (2) 00177-2019; 10.1183/23120541.00177-2019 Year: 2020
Impact of early referral to palliative care in patients with interstitial lung disease Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021
Which severe COVID-19 patients may benefit the most from pulmonary rehabilitation? Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation Year: 2021
Integrating early palliative care for patients with idiopathic pulmonary fibrosis and their caregivers Source: Virtual Congress 2020 – Fear and anxiety, psychological wellbeing and prevention of psychological distress in chronic lung diseases Year: 2020
Should patients with pulmonary fibrosis be admitted to intensive care? Source: Eur Respir J 2006; 28: Suppl. 50, 347s Year: 2006
Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis Source: Eur Respir J, 54 (6) 1901188; 10.1183/13993003.01188-2019 Year: 2019
The effectiveness of pulmonary rehabilitation in patients diagnosed with interstitial pulmonary fibrosis Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020
Influence of pulmonary rehabilitation in patients with COPD on use of primary and secondary care resources Source: Annual Congress 2003 - Outcome of pulmonary rehabilitation Year: 2003
Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry Source: ERJ Open Res, 5 (3) 00170-2018; 10.1183/23120541.00170-2018 Year: 2019
Long-term benefits of pulmonary rehabilitation in patients with chronic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 454s Year: 2002
Improvements in short- and long-term outcomes in patients with pulmonary embolism after outpatient pulmonary rehabilitation Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020